JDOC · JPMorgan Healthcare Leaders ETF
J.P. Morgan Exchange-Traded Fund Trust
$67.00
-0.78%
At close · Nov 12
Net assets $9,074,769
Holdings61
1 month
+7.23%
Year to date
+15.82%
52-week range
$53.87–$67.72
30-session avg volume
789
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000080528
- Report date
- Jul 31, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings48.10%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC99.20%
STIV0.00%
Country allocation
US75.20%
GB6.23%
CH4.42%
DK4.03%
JP2.47%
NL2.36%
DE1.86%
Other2.63%
Portfolio holdings
Latest linked SEC Form NPORT-P report. Pull holdings through the ETF holdings API or MCP →
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| AbbVie, Inc. | ABBV | $712,168 | 7.85% |
| Eli Lilly & Co. | LLY | $704,239 | 7.76% |
| UnitedHealth Group, Inc. | UNH | $530,846 | 5.85% |
| Merck & Co., Inc. | MRK | $437,342 | 4.82% |
| Johnson & Johnson | JNJ | $437,333 | 4.82% |
| AstraZeneca plc | $341,411 | 3.76% | |
| Thermo Fisher Scientific, Inc. | TMO | $338,837 | 3.73% |
| Bristol-Myers Squibb Co. | BMY | $324,068 | 3.57% |
| Abbott Laboratories | ABT | $282,113 | 3.11% |
| CVS Health Corp. | CVS | $256,689 | 2.83% |
| Roche Holding AG | $256,136 | 2.82% | |
| Novo Nordisk A/S | $237,170 | 2.61% | |
| GSK plc | $223,755 | 2.47% | |
| Stryker Corp. | SYK | $201,934 | 2.23% |
| Danaher Corp. | DHR | $196,150 | 2.16% |
| Cencora, Inc. | COR | $188,049 | 2.07% |
| Argenx SE | $186,716 | 2.06% | |
| Intuitive Surgical, Inc. | ISRG | $175,252 | 1.93% |
| Edwards Lifesciences Corp. | EW | $157,250 | 1.73% |
| IQVIA Holdings, Inc. | IQV | $155,348 | 1.71% |
| Teva Pharmaceutical Industries Ltd. | $145,306 | 1.60% | |
| Regeneron Pharmaceuticals, Inc. | REGN | $144,900 | 1.60% |
| Novartis AG | $144,819 | 1.60% | |
| Biogen, Inc. | BIIB | $141,862 | 1.56% |
| Cardinal Health, Inc. | CAH | $137,328 | 1.51% |
| Takeda Pharmaceutical Co. Ltd. | $116,741 | 1.29% | |
| Centene Corp. | CNC | $108,263 | 1.19% |
| Hoya Corp. | $107,042 | 1.18% | |
| Humana, Inc. | HUM | $105,519 | 1.16% |
| Boston Scientific Corp. | BSX | $96,684 | 1.07% |
| Fresenius SE & Co. KGaA | $94,108 | 1.04% | |
| Insmed, Inc. | INSM | $88,148 | 0.97% |
| Genmab A/S | $75,702 | 0.83% | |
| Sartorius AG | $75,106 | 0.83% | |
| Dyne Therapeutics, Inc. | DYN | $74,734 | 0.82% |
| Vertex Pharmaceuticals, Inc. | VRTX | $73,951 | 0.81% |
| Spyre Therapeutics, Inc. | SYRE | $69,814 | 0.77% |
| Neurocrine Biosciences, Inc. | NBIX | $66,553 | 0.73% |
| Bridgebio Pharma, Inc. | BBIO | $65,834 | 0.73% |
| Alnylam Pharmaceuticals, Inc. | ALNY | $63,917 | 0.70% |
| Align Technology, Inc. | ALGN | $63,604 | 0.70% |
| Charles River Laboratories International, Inc. | CRL | $60,220 | 0.66% |
| CG oncology, Inc. | CGON | $56,311 | 0.62% |
| Ascendis Pharma A/S | $53,172 | 0.59% | |
| Alumis, Inc. | ALMS | $51,811 | 0.57% |
| LB Pharmaceuticals, Inc. | LBRX | $50,421 | 0.56% |
| Disc Medicine, Inc. | IRON | $46,200 | 0.51% |
| PTC Therapeutics, Inc. | PTCT | $44,751 | 0.49% |
| Bicara Therapeutics, Inc. | BCAX | $40,216 | 0.44% |
| Arcus Biosciences, Inc. | RCUS | $39,015 | 0.43% |
Showing the top 50 of 61 holdings. Create a free account to see every holding and download the CSV.